{"transactions":[{"id":2092000,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-12-08T22:18:49.000Z","date":"2022-12-06","kind":"sale","acquired":false,"shares":1023,"price":27.03,"value":27651.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022."}],"balance_after":65970,"source":{"system":"sec-edgar","filing":"0001384101-22-000157","document":"wf-form4_167053791573091.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000157/wf-form4_167053791573091.xml","form_type":"4"}},{"id":2094223,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-12-06T22:19:17.000Z","date":"2022-12-02","kind":"tax_withholding","acquired":false,"shares":1008,"price":29.14,"value":29373.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 248, 372, and 388 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 500, 750 and 781 Restricted Stock Units, respectively, granted on February 28, 2019, February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person."}],"balance_after":66993,"source":{"system":"sec-edgar","filing":"0001384101-22-000155","document":"wf-form4_167036513618601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000155/wf-form4_167036513618601.xml","form_type":"4"}},{"id":2115896,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-15T22:02:02.000Z","date":"2022-11-11","kind":"exercise","acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":14.34,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0001384101-22-000145","document":"wf-form4_166854970597951.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000145/wf-form4_166854970597951.xml","form_type":"4"}},{"id":2115895,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-11-15T22:02:02.000Z","date":"2022-11-11","kind":"sale","acquired":false,"shares":2,"price":29.34,"value":58.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022."}],"balance_after":68001,"source":{"system":"sec-edgar","filing":"0001384101-22-000145","document":"wf-form4_166854970597951.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000145/wf-form4_166854970597951.xml","form_type":"4"}},{"id":2115894,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-11-15T22:02:02.000Z","date":"2022-11-11","kind":"exercise","acquired":true,"shares":2,"price":14.34,"value":28.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022."}],"balance_after":68003,"source":{"system":"sec-edgar","filing":"0001384101-22-000145","document":"wf-form4_166854970597951.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000145/wf-form4_166854970597951.xml","form_type":"4"}},{"id":2122044,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-11-08T22:44:48.000Z","date":"2022-11-04","kind":"sale","acquired":false,"shares":1023,"price":25,"value":25575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022."}],"balance_after":68001,"source":{"system":"sec-edgar","filing":"0001384101-22-000141","document":"wf-form4_166794747255272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000141/wf-form4_166794747255272.xml","form_type":"4"}},{"id":2164008,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-09-07T20:57:14.000Z","date":"2022-09-02","kind":"tax_withholding","acquired":false,"shares":1008,"price":19.18,"value":19333.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 248, 372, and 388 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 500, 750 and 781 Restricted Stock Units, respectively, granted on February 28, 2019, February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person."}],"balance_after":69024,"source":{"system":"sec-edgar","filing":"0001384101-22-000131","document":"wf-form4_166258421424158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000131/wf-form4_166258421424158.xml","form_type":"4"}},{"id":2190557,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-09T21:16:29.000Z","date":"2022-08-05","kind":"exercise","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.43,"expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001384101-22-000113","document":"wf-form4_166007975334441.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000113/wf-form4_166007975334441.xml","form_type":"4"}},{"id":2190556,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-09T21:16:29.000Z","date":"2022-08-05","kind":"exercise","acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.45,"expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0001384101-22-000113","document":"wf-form4_166007975334441.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000113/wf-form4_166007975334441.xml","form_type":"4"}},{"id":2190555,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-09T21:16:29.000Z","date":"2022-08-05","kind":"exercise","acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.45,"expiration_date":"2024-09-15","underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0001384101-22-000113","document":"wf-form4_166007975334441.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000113/wf-form4_166007975334441.xml","form_type":"4"}},{"id":2190554,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-09T21:16:29.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":18248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable as to 1/3rd of the shares on August 5, 2023, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":18248,"derivative":{"exercise_price":27.9,"expiration_date":"2032-08-05","underlying":"Common Stock","underlying_shares":18248},"source":{"system":"sec-edgar","filing":"0001384101-22-000113","document":"wf-form4_166007975334441.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000113/wf-form4_166007975334441.xml","form_type":"4"}},{"id":2190553,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-08-09T21:16:29.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":1028,"price":26.54,"value":27283.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022."}],"balance_after":70032,"source":{"system":"sec-edgar","filing":"0001384101-22-000113","document":"wf-form4_166007975334441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000113/wf-form4_166007975334441.xml","form_type":"4"}},{"id":2190552,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-08-09T21:16:29.000Z","date":"2022-08-05","kind":"exercise","acquired":true,"shares":1,"price":5.43,"value":5.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022."}],"balance_after":71060,"source":{"system":"sec-edgar","filing":"0001384101-22-000113","document":"wf-form4_166007975334441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000113/wf-form4_166007975334441.xml","form_type":"4"}},{"id":2190551,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-08-09T21:16:29.000Z","date":"2022-08-05","kind":"exercise","acquired":true,"shares":2,"price":6.45,"value":12.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022."}],"balance_after":71059,"source":{"system":"sec-edgar","filing":"0001384101-22-000113","document":"wf-form4_166007975334441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000113/wf-form4_166007975334441.xml","form_type":"4"}},{"id":2190550,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-08-09T21:16:29.000Z","date":"2022-08-05","kind":"exercise","acquired":true,"shares":2,"price":10.45,"value":20.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022."}],"balance_after":71057,"source":{"system":"sec-edgar","filing":"0001384101-22-000113","document":"wf-form4_166007975334441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000113/wf-form4_166007975334441.xml","form_type":"4"}},{"id":2190549,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-08-09T21:16:29.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":10702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on August 5, 2022 vest 1/3rd on September 2, 2023 and 1/12th per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":71055,"source":{"system":"sec-edgar","filing":"0001384101-22-000113","document":"wf-form4_166007975334441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000113/wf-form4_166007975334441.xml","form_type":"4"}},{"id":2241485,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-06-06T20:22:07.000Z","date":"2022-06-02","kind":"tax_withholding","acquired":false,"shares":1008,"price":18.23,"value":18375.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 248, 372, and 388 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 500, 750 and 781 Restricted Stock Units, respectively, granted on February 28, 2019, February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person."}],"balance_after":60353,"source":{"system":"sec-edgar","filing":"0001384101-22-000074","document":"wf-form4_165454691147897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000074/wf-form4_165454691147897.xml","form_type":"4"}},{"id":2341300,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-10T01:46:11.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":4407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.98,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":4407},"source":{"system":"sec-edgar","filing":"0001384101-22-000054","document":"wf-form4a_164687675656053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000054/wf-form4a_164687675656053.xml","form_type":"4/A","original_submission_date":"2022-03-07"}},{"id":2341299,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-10T01:46:11.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":77287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option becomes exercisable as to 25% of the shares on March 3, 2023, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":77287,"derivative":{"exercise_price":26.02,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":77287},"source":{"system":"sec-edgar","filing":"0001384101-22-000054","document":"wf-form4a_164687675656053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000054/wf-form4a_164687675656053.xml","form_type":"4/A","original_submission_date":"2022-03-07"}},{"id":2341298,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-03-10T01:46:11.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":100,"price":26.49,"value":2649.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":61361,"source":{"system":"sec-edgar","filing":"0001384101-22-000054","document":"wf-form4a_164687675656053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000054/wf-form4a_164687675656053.xml","form_type":"4/A","original_submission_date":"2022-03-07"}},{"id":2341297,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-03-10T01:46:11.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":5844,"price":25.6997,"value":150189.0468,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price.  Sale prices for the transactions range from $25.41 to $26.26.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":61461,"source":{"system":"sec-edgar","filing":"0001384101-22-000054","document":"wf-form4a_164687675656053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000054/wf-form4a_164687675656053.xml","form_type":"4/A","original_submission_date":"2022-03-07"}},{"id":2341296,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-03-10T01:46:11.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":17089,"price":24.9106,"value":425697.2434,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price.  Sale prices for the transactions range from $24.40 to $25.40.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":67305,"source":{"system":"sec-edgar","filing":"0001384101-22-000054","document":"wf-form4a_164687675656053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000054/wf-form4a_164687675656053.xml","form_type":"4/A","original_submission_date":"2022-03-07"}},{"id":2341295,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-03-10T01:46:11.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":4407,"price":5.98,"value":26353.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":84394,"source":{"system":"sec-edgar","filing":"0001384101-22-000054","document":"wf-form4a_164687675656053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000054/wf-form4a_164687675656053.xml","form_type":"4/A","original_submission_date":"2022-03-07"}},{"id":2341294,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-03-10T01:46:11.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":42412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on March 3, 2022 vest 25% on March 2, 2023 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":79987,"source":{"system":"sec-edgar","filing":"0001384101-22-000054","document":"wf-form4a_164687675656053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000054/wf-form4a_164687675656053.xml","form_type":"4/A","original_submission_date":"2022-03-07"}},{"id":2347275,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-07T21:34:18.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":4407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.98,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":4407},"source":{"system":"sec-edgar","filing":"0001384101-22-000046","document":"wf-form4_164668883673823.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000046/wf-form4_164668883673823.xml","form_type":"4"}},{"id":2347274,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-07T21:34:18.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":77287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option becomes exercisable as to 25% of the shares on March 3, 2023, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":77287,"derivative":{"exercise_price":26.02,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":77287},"source":{"system":"sec-edgar","filing":"0001384101-22-000046","document":"wf-form4_164668883673823.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000046/wf-form4_164668883673823.xml","form_type":"4"}},{"id":2347273,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-03-07T21:34:18.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":100,"price":26.49,"value":2649.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":61391,"source":{"system":"sec-edgar","filing":"0001384101-22-000046","document":"wf-form4_164668883673823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000046/wf-form4_164668883673823.xml","form_type":"4"}},{"id":2347272,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-03-07T21:34:18.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":5844,"price":25.6997,"value":150189.0468,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price.  Sale prices for the transactions range from $25.41 to $26.26.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":61491,"source":{"system":"sec-edgar","filing":"0001384101-22-000046","document":"wf-form4_164668883673823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000046/wf-form4_164668883673823.xml","form_type":"4"}},{"id":2347271,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-03-07T21:34:18.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":17059,"price":24.9103,"value":424944.8077,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price.  Sale prices for the transactions range from $24.40 to $25.40.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":67335,"source":{"system":"sec-edgar","filing":"0001384101-22-000046","document":"wf-form4_164668883673823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000046/wf-form4_164668883673823.xml","form_type":"4"}},{"id":2347270,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-03-07T21:34:18.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":4407,"price":5.98,"value":26353.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":84394,"source":{"system":"sec-edgar","filing":"0001384101-22-000046","document":"wf-form4_164668883673823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000046/wf-form4_164668883673823.xml","form_type":"4"}},{"id":2347269,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-03-07T21:34:18.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":42412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on March 3, 2022 vest 25% on March 2, 2023 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":79987,"source":{"system":"sec-edgar","filing":"0001384101-22-000046","document":"wf-form4_164668883673823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000046/wf-form4_164668883673823.xml","form_type":"4"}},{"id":2349793,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2022-03-04T22:31:37.000Z","date":"2022-03-02","kind":"tax_withholding","acquired":false,"shares":10337,"price":27.84,"value":287782.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 241, 173, 8,582, 260 and 1,081 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 588, 500, 24,000, 750 and 3,125 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019, February 28, 2019, February 28, 2020 and February 26, 2021 respectively, and does not represent a sale by the reporting person."}],"balance_after":37575,"source":{"system":"sec-edgar","filing":"0001384101-22-000040","document":"wf-form4_164643307661177.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410122000040/wf-form4_164643307661177.xml","form_type":"4"}},{"id":2480259,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T21:42:10.000Z","date":"2021-12-07","kind":"exercise","acquired":false,"shares":1750,"price":26.55,"value":46462.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":26.55,"expiration_date":"2030-05-10","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001384101-21-000180","document":"wf-form4_163899971487247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000180/wf-form4_163899971487247.xml","form_type":"4"}},{"id":2480258,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T21:42:10.000Z","date":"2021-12-07","kind":"exercise","acquired":false,"shares":4375,"price":24.69,"value":108018.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuousservice thereafter."}],"balance_after":39375,"derivative":{"exercise_price":24.69,"expiration_date":"2030-03-27","underlying":"Common Stock","underlying_shares":4375},"source":{"system":"sec-edgar","filing":"0001384101-21-000180","document":"wf-form4_163899971487247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000180/wf-form4_163899971487247.xml","form_type":"4"}},{"id":2480257,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T21:42:10.000Z","date":"2021-12-06","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":18750,"derivative":{"exercise_price":20.21,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001384101-21-000180","document":"wf-form4_163899971487247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000180/wf-form4_163899971487247.xml","form_type":"4"}},{"id":2480256,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T21:42:10.000Z","date":"2021-12-06","kind":"exercise","acquired":false,"shares":4406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":4407,"derivative":{"exercise_price":5.98,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":4406},"source":{"system":"sec-edgar","filing":"0001384101-21-000180","document":"wf-form4_163899971487247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000180/wf-form4_163899971487247.xml","form_type":"4"}},{"id":2480255,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-12-08T21:42:10.000Z","date":"2021-12-07","kind":"sale","acquired":false,"shares":1750,"price":41.55,"value":72712.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":47912,"source":{"system":"sec-edgar","filing":"0001384101-21-000180","document":"wf-form4_163899971487247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000180/wf-form4_163899971487247.xml","form_type":"4"}},{"id":2480254,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-12-08T21:42:10.000Z","date":"2021-12-07","kind":"sale","acquired":false,"shares":4375,"price":39.69,"value":173643.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":49662,"source":{"system":"sec-edgar","filing":"0001384101-21-000180","document":"wf-form4_163899971487247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000180/wf-form4_163899971487247.xml","form_type":"4"}},{"id":2480253,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-12-08T21:42:10.000Z","date":"2021-12-07","kind":"exercise","acquired":true,"shares":1750,"price":26.55,"value":46462.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":54037,"source":{"system":"sec-edgar","filing":"0001384101-21-000180","document":"wf-form4_163899971487247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000180/wf-form4_163899971487247.xml","form_type":"4"}},{"id":2480252,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-12-08T21:42:10.000Z","date":"2021-12-07","kind":"exercise","acquired":true,"shares":4375,"price":24.69,"value":108018.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":52287,"source":{"system":"sec-edgar","filing":"0001384101-21-000180","document":"wf-form4_163899971487247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000180/wf-form4_163899971487247.xml","form_type":"4"}},{"id":2480251,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-12-08T21:42:10.000Z","date":"2021-12-06","kind":"sale","acquired":false,"shares":1785,"price":37.2604,"value":66509.814,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price.  Sale prices for the transactions range from $36.88 to $37.66.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":47912,"source":{"system":"sec-edgar","filing":"0001384101-21-000180","document":"wf-form4_163899971487247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000180/wf-form4_163899971487247.xml","form_type":"4"}},{"id":2480250,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-12-08T21:42:10.000Z","date":"2021-12-06","kind":"sale","acquired":false,"shares":3897,"price":36.1071,"value":140709.3687,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price.  Sale prices for the transactions range from $35.79 to $36.74.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":49697,"source":{"system":"sec-edgar","filing":"0001384101-21-000180","document":"wf-form4_163899971487247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000180/wf-form4_163899971487247.xml","form_type":"4"}},{"id":2480249,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-12-08T21:42:10.000Z","date":"2021-12-06","kind":"sale","acquired":false,"shares":3550,"price":35.3704,"value":125564.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $34.70 to $35.70.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":53594,"source":{"system":"sec-edgar","filing":"0001384101-21-000180","document":"wf-form4_163899971487247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000180/wf-form4_163899971487247.xml","form_type":"4"}},{"id":2480248,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-12-08T21:42:10.000Z","date":"2021-12-06","kind":"exercise","acquired":true,"shares":3750,"price":20.21,"value":75787.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":57144,"source":{"system":"sec-edgar","filing":"0001384101-21-000180","document":"wf-form4_163899971487247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000180/wf-form4_163899971487247.xml","form_type":"4"}},{"id":2480247,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-12-08T21:42:10.000Z","date":"2021-12-06","kind":"exercise","acquired":true,"shares":4406,"price":5.98,"value":26347.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":53394,"source":{"system":"sec-edgar","filing":"0001384101-21-000180","document":"wf-form4_163899971487247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000180/wf-form4_163899971487247.xml","form_type":"4"}},{"id":2483478,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-12-06T22:24:33.000Z","date":"2021-12-02","kind":"tax_withholding","acquired":false,"shares":912,"price":39.22,"value":35768.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 292, 248 and 372 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 587, 500 and 750 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019 and February 28, 2020 respectively, and does not represent a sale by the reporting person."}],"balance_after":48988,"source":{"system":"sec-edgar","filing":"0001384101-21-000176","document":"wf-form4_163882945893577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000176/wf-form4_163882945893577.xml","form_type":"4"}},{"id":2525818,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-11-03T21:16:56.000Z","date":"2021-11-01","kind":"tax_withholding","acquired":false,"shares":149,"price":51.8,"value":7718.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 149 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 300 Restricted Stock Units, respectively, granted on May 11, 2020, and does not represent a sale by the reporting person."}],"balance_after":49900,"source":{"system":"sec-edgar","filing":"0001384101-21-000161","document":"wf-form4_163597419799661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000161/wf-form4_163597419799661.xml","form_type":"4"}},{"id":2574493,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-09T21:07:35.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":4375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":43750,"derivative":{"exercise_price":24.69,"expiration_date":"2030-03-27","underlying":"Common Stock","underlying_shares":4375},"source":{"system":"sec-edgar","filing":"0001384101-21-000155","document":"wf-form4_163122163694896.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000155/wf-form4_163122163694896.xml","form_type":"4"}},{"id":2574492,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-09T21:07:35.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":22500,"derivative":{"exercise_price":20.21,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001384101-21-000155","document":"wf-form4_163122163694896.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000155/wf-form4_163122163694896.xml","form_type":"4"}},{"id":2574491,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-09T21:07:35.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":4406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":8813,"derivative":{"exercise_price":5.98,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":4406},"source":{"system":"sec-edgar","filing":"0001384101-21-000155","document":"wf-form4_163122163694896.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000155/wf-form4_163122163694896.xml","form_type":"4"}},{"id":2574490,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-09-09T21:07:35.000Z","date":"2021-09-08","kind":"sale","acquired":false,"shares":926,"price":50.53,"value":46790.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":50049,"source":{"system":"sec-edgar","filing":"0001384101-21-000155","document":"wf-form4_163122163694896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000155/wf-form4_163122163694896.xml","form_type":"4"}},{"id":2574489,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-09-09T21:07:35.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":497,"price":51.233,"value":25462.801,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price.  Sale prices for the transactions range from $51.07 to $51.33.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":50975,"source":{"system":"sec-edgar","filing":"0001384101-21-000155","document":"wf-form4_163122163694896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000155/wf-form4_163122163694896.xml","form_type":"4"}},{"id":2574488,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-09-09T21:07:35.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":12034,"price":50.519,"value":607945.646,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $50.06 to $51.06.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":51472,"source":{"system":"sec-edgar","filing":"0001384101-21-000155","document":"wf-form4_163122163694896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000155/wf-form4_163122163694896.xml","form_type":"4"}},{"id":2574487,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-09-09T21:07:35.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":4375,"price":24.69,"value":108018.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":63506,"source":{"system":"sec-edgar","filing":"0001384101-21-000155","document":"wf-form4_163122163694896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000155/wf-form4_163122163694896.xml","form_type":"4"}},{"id":2574486,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-09-09T21:07:35.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":3750,"price":20.21,"value":75787.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":59131,"source":{"system":"sec-edgar","filing":"0001384101-21-000155","document":"wf-form4_163122163694896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000155/wf-form4_163122163694896.xml","form_type":"4"}},{"id":2574485,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-09-09T21:07:35.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":4406,"price":5.98,"value":26347.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021."}],"balance_after":55381,"source":{"system":"sec-edgar","filing":"0001384101-21-000155","document":"wf-form4_163122163694896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000155/wf-form4_163122163694896.xml","form_type":"4"}},{"id":2576992,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-09-07T21:11:47.000Z","date":"2021-09-02","kind":"tax_withholding","acquired":false,"shares":912,"price":52.97,"value":48308.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 292, 248 and 372 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 588, 500 and 750 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019 and February 28, 2020 respectively, and does not represent a sale by the reporting person."}],"balance_after":50975,"source":{"system":"sec-edgar","filing":"0001384101-21-000150","document":"wf-form4_163104909320686.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000150/wf-form4_163104909320686.xml","form_type":"4"}},{"id":2654506,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-25T20:12:47.000Z","date":"2021-06-23","kind":"exercise","acquired":false,"shares":4375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":48125,"derivative":{"exercise_price":24.69,"expiration_date":"2030-03-27","underlying":"Common Stock","underlying_shares":4375},"source":{"system":"sec-edgar","filing":"0001384101-21-000116","document":"wf-form4_162465194522576.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000116/wf-form4_162465194522576.xml","form_type":"4"}},{"id":2654505,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-06-25T20:12:47.000Z","date":"2021-06-23","kind":"sale","acquired":false,"shares":4375,"price":39.7517,"value":173913.6875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $39.69 to $39.84.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":51887,"source":{"system":"sec-edgar","filing":"0001384101-21-000116","document":"wf-form4_162465194522576.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000116/wf-form4_162465194522576.xml","form_type":"4"}},{"id":2654504,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-06-25T20:12:47.000Z","date":"2021-06-23","kind":"exercise","acquired":true,"shares":4375,"price":24.69,"value":108018.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."}],"balance_after":56262,"source":{"system":"sec-edgar","filing":"0001384101-21-000116","document":"wf-form4_162465194522576.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000116/wf-form4_162465194522576.xml","form_type":"4"}},{"id":2677136,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-08T20:38:25.000Z","date":"2021-06-04","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":26250,"derivative":{"exercise_price":20.21,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001384101-21-000101","document":"wf-form4_162318467981821.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000101/wf-form4_162318467981821.xml","form_type":"4"}},{"id":2677135,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-08T20:38:25.000Z","date":"2021-06-04","kind":"exercise","acquired":false,"shares":4406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter"}],"balance_after":13219,"derivative":{"exercise_price":5.98,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":4406},"source":{"system":"sec-edgar","filing":"0001384101-21-000101","document":"wf-form4_162318467981821.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000101/wf-form4_162318467981821.xml","form_type":"4"}},{"id":2677134,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-06-08T20:38:25.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":4979,"price":35.1702,"value":175112.4258,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price.  Sale prices for the transactions range from $34.95 to $35.27.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":51887,"source":{"system":"sec-edgar","filing":"0001384101-21-000101","document":"wf-form4_162318467981821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000101/wf-form4_162318467981821.xml","form_type":"4"}},{"id":2677133,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-06-08T20:38:25.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":2595,"price":34.3936,"value":89251.392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price.  Sale prices for the transactions range from $33.93 to $34.93.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":56866,"source":{"system":"sec-edgar","filing":"0001384101-21-000101","document":"wf-form4_162318467981821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000101/wf-form4_162318467981821.xml","form_type":"4"}},{"id":2677132,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-06-08T20:38:25.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":1507,"price":33.279,"value":50151.453,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $32.92 to $33.68.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":59461,"source":{"system":"sec-edgar","filing":"0001384101-21-000101","document":"wf-form4_162318467981821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000101/wf-form4_162318467981821.xml","form_type":"4"}},{"id":2677131,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-06-08T20:38:25.000Z","date":"2021-06-04","kind":"exercise","acquired":true,"shares":3750,"price":20.21,"value":75787.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."}],"balance_after":60968,"source":{"system":"sec-edgar","filing":"0001384101-21-000101","document":"wf-form4_162318467981821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000101/wf-form4_162318467981821.xml","form_type":"4"}},{"id":2677130,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-06-08T20:38:25.000Z","date":"2021-06-04","kind":"exercise","acquired":true,"shares":4406,"price":5.98,"value":26347.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."}],"balance_after":57218,"source":{"system":"sec-edgar","filing":"0001384101-21-000101","document":"wf-form4_162318467981821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000101/wf-form4_162318467981821.xml","form_type":"4"}},{"id":2680561,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-06-04T20:56:28.000Z","date":"2021-06-02","kind":"tax_withholding","acquired":false,"shares":912,"price":36.07,"value":32895.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 292, 248 and 372 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 587, 500 and 750 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019 and February 28, 2020 respectively, and does not represent a sale by the reporting person."}],"balance_after":52812,"source":{"system":"sec-edgar","filing":"0001384101-21-000096","document":"wf-form4_162284014712611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000096/wf-form4_162284014712611.xml","form_type":"4"}},{"id":2802678,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"exercise","acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":52500,"derivative":{"exercise_price":24.69,"expiration_date":"2030-03-27","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802677,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":30000,"derivative":{"exercise_price":20.21,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802676,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"exercise","acquired":false,"shares":4407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":17625,"derivative":{"exercise_price":5.98,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":4407},"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802675,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"exercise","acquired":false,"shares":5313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.05,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":5313},"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802674,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":300,"price":55.49,"value":16647.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents weighted average sales price.  Sale prices for the transactions range from $55.31 to $55.67.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":53724,"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802673,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":1431,"price":54.724,"value":78310.044,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents weighted average sales price.  Sale prices for the transactions range from $54.11 to $55.10.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":54024,"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802672,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":2606,"price":53.4975,"value":139414.485,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents weighted average sales price.  Sale prices for the transactions range from $52.99 to $53.99.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":55455,"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802671,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":5032,"price":52.3776,"value":263564.0832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents weighted average sales price.  Sale prices for the transactions range from $51.94 to $52.93.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":58061,"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802670,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":8114,"price":51.3804,"value":416900.5656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents weighted average sales price.  Sale prices for the transactions range from $50.90 to $51.89.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":63093,"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802669,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":2819,"price":50.3985,"value":142073.3715,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents weighted average sales price.  Sale prices for the transactions range from $49.87 to $50.87.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":71207,"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802668,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":2991,"price":49.2176,"value":147209.8416,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price.  Sale prices for the transactions range from $48.82 to $49.81.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":74026,"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802667,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":8483,"price":48.2857,"value":409607.5931,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price.  Sale prices for the transactions range from $47.80 to $48.80.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":77017,"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802666,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":20239,"price":47.1142,"value":953544.2938,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $46.78 to $47.78.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":85500,"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802665,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"exercise","acquired":true,"shares":17500,"price":24.69,"value":432075.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."}],"balance_after":105739,"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802664,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"exercise","acquired":true,"shares":3750,"price":20.21,"value":75787.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."}],"balance_after":88239,"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802663,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"exercise","acquired":true,"shares":4407,"price":5.98,"value":26353.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."}],"balance_after":84489,"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2802662,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-08T22:33:32.000Z","date":"2021-03-04","kind":"exercise","acquired":true,"shares":5313,"price":9.05,"value":48082.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."}],"balance_after":80082,"source":{"system":"sec-edgar","filing":"0001384101-21-000044","document":"wf-form4_161524279377824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000044/wf-form4_161524279377824.xml","form_type":"4"}},{"id":2808299,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-04T22:05:58.000Z","date":"2021-03-02","kind":"tax_withholding","acquired":false,"shares":5995,"price":62.15,"value":372589.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 292, 248, 3,967 and 1,488 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 588, 500, 8,000 and 3,000 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019, February 28, 2019 and February 28, 2020 respectively, and does not represent a saleby the reporting person."}],"balance_after":74769,"source":{"system":"sec-edgar","filing":"0001384101-21-000038","document":"wf-form4_161489554524867.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000038/wf-form4_161489554524867.xml","form_type":"4"}},{"id":2819082,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T22:19:30.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as to 25% of the shares on February 26, 2022, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":25000,"derivative":{"exercise_price":58.06,"expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001384101-21-000028","document":"wf-form4_161472354334446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000028/wf-form4_161472354334446.xml","form_type":"4"}},{"id":2819081,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-03-02T22:19:30.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on February 26, 2021 vest 25% on March 2, 2022 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":80764,"source":{"system":"sec-edgar","filing":"0001384101-21-000028","document":"wf-form4_161472354334446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000028/wf-form4_161472354334446.xml","form_type":"4"}},{"id":2829127,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2021-02-26T21:41:07.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":10048,"price":62.3,"value":625990.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding of 10,048 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 25,000 Performance Stock Units vested on February 24, 2021 and does not represent a sale by the reporting person."}],"balance_after":68264,"source":{"system":"sec-edgar","filing":"0001384101-21-000020","document":"wf-form4_161437563530725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410121000020/wf-form4_161437563530725.xml","form_type":"4"}},{"id":2956333,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"officer":true,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-05T00:42:09.000Z","date":"2020-12-04","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous\nservice thereafter."}],"balance_after":33750,"derivative":{"exercise_price":20.21,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001437749-20-024903","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000143774920024903/rdgdoc.xml","form_type":"4"}},{"id":2956332,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"officer":true,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-05T00:42:09.000Z","date":"2020-12-04","kind":"exercise","acquired":false,"shares":4406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous\nservice thereafter."}],"balance_after":22032,"derivative":{"exercise_price":5.98,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":4406},"source":{"system":"sec-edgar","filing":"0001437749-20-024903","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000143774920024903/rdgdoc.xml","form_type":"4"}},{"id":2956331,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"officer":true,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-05T00:42:09.000Z","date":"2020-12-04","kind":"exercise","acquired":false,"shares":5312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous\nservice thereafter."}],"balance_after":5313,"derivative":{"exercise_price":9.05,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":5312},"source":{"system":"sec-edgar","filing":"0001437749-20-024903","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000143774920024903/rdgdoc.xml","form_type":"4"}},{"id":2956330,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"officer":true,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2020-12-05T00:42:09.000Z","date":"2020-12-04","kind":"sale","acquired":false,"shares":6094,"price":57.5536,"value":350731.6384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents weighted average sales price. Sale prices for the transactions range from $57.31 to $57.90. Detailed information regarding the number of shares sold at each separate price will be provided to the\nSEC, the issuer or a shareholder upon request."}],"balance_after":78312,"source":{"system":"sec-edgar","filing":"0001437749-20-024903","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000143774920024903/rdgdoc.xml","form_type":"4"}},{"id":2956329,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"officer":true,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2020-12-05T00:42:09.000Z","date":"2020-12-04","kind":"sale","acquired":false,"shares":4279,"price":56.8555,"value":243284.6845,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price. Sale prices for the transactions range from $56.28 to $57.11. Detailed information regarding the number of shares sold at each separate price will be provided to the\nSEC, the issuer or a shareholder upon request."}],"balance_after":84406,"source":{"system":"sec-edgar","filing":"0001437749-20-024903","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000143774920024903/rdgdoc.xml","form_type":"4"}},{"id":2956328,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"officer":true,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2020-12-05T00:42:09.000Z","date":"2020-12-04","kind":"sale","acquired":false,"shares":3642,"price":55.777,"value":203139.834,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price. Sale prices for the transactions range from $55.27 to $56.13. Detailed information regarding the number of shares sold at each separate price will be provided to the\nSEC, the issuer or a shareholder upon request."}],"balance_after":88685,"source":{"system":"sec-edgar","filing":"0001437749-20-024903","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000143774920024903/rdgdoc.xml","form_type":"4"}},{"id":2956327,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"officer":true,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2020-12-05T00:42:09.000Z","date":"2020-12-04","kind":"exercise","acquired":true,"shares":3750,"price":20.21,"value":75787.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."}],"balance_after":92327,"source":{"system":"sec-edgar","filing":"0001437749-20-024903","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000143774920024903/rdgdoc.xml","form_type":"4"}},{"id":2956326,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"officer":true,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2020-12-05T00:42:09.000Z","date":"2020-12-04","kind":"exercise","acquired":true,"shares":4406,"price":5.98,"value":26347.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."}],"balance_after":88577,"source":{"system":"sec-edgar","filing":"0001437749-20-024903","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000143774920024903/rdgdoc.xml","form_type":"4"}},{"id":2956325,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"officer":true,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2020-12-05T00:42:09.000Z","date":"2020-12-04","kind":"exercise","acquired":true,"shares":5312,"price":9.05,"value":48073.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."}],"balance_after":84171,"source":{"system":"sec-edgar","filing":"0001437749-20-024903","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000143774920024903/rdgdoc.xml","form_type":"4"}},{"id":2956324,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"officer":true,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2020-12-05T00:42:09.000Z","date":"2020-12-02","kind":"tax_withholding","acquired":false,"shares":540,"price":55.08,"value":29743.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 292 and 248 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 587 and 500 Restricted Stock Units, respectively granted on March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person."}],"balance_after":78859,"source":{"system":"sec-edgar","filing":"0001437749-20-024903","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000143774920024903/rdgdoc.xml","form_type":"4"}},{"id":3010673,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":121767,"kind":"person","name":"Kennedy Giulia C","position":1,"cik":"0001769333","reported_name":"Kennedy Giulia C","relationship":{"officer":true,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-07T21:06:03.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous\nservice thereafter."}],"balance_after":37500,"derivative":{"exercise_price":20.21,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001437749-20-020855","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000143774920020855/rdgdoc.xml","form_type":"4"}}],"next_cursor":"2020-10-07T21:06:03.000000Z,3010673"}